¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Le Fort III fracture"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hairline fracture
    °¡´Â¼±°ñÀý
  • hangman¡¯s fracture
    ±³¼öÇü°ñÀý
  • isolated fracture
    ´Üµ¶°ñÀý
  • impacted fracture
    ³¢ÀÓ°ñÀý, °¨ÀÔ°ñÀý
  • incomplete fracture
    ºÒ¿ÏÀü°ñÀý
  • inflammatory fracture
    ¿°Áõ°ñÀý
  • lead pipe fracture
    ³³°ü°ñÀý, ³³ÆÄÀÌÇÁ°ñÀý
  • linear fracture
    ¼±°ñÀý, ¼±»ó°ñÀý
  • longitudinal fracture
    ¼¼·Î°ñÀý
  • loop fracture
    °í¸®°ñÀý
  • loose fracture
    À¯¸®°ñÀý
  • multiple fracture
    ´Ù¹ß°ñÀý
  • march fracture
    Ç౺°ñÀý
  • neoplastic fracture
    Á¾¾ç°ñÀý
  • nasal bone fracture
    ÄÚ»À°ñÀý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • linear skull fracture
    ¼±»ó¸Ó¸®°ñÀý, µÎ°³°ñ¼±»ó°ñÀý
  • longitudinal fracture
    ¼¼·Î°ñÀý
  • loop fracture
    °í¸®°ñÀý
  • loose fracture
    À¯¸®°ñÀý
  • march fracture
    Ç౺°ñÀý
  • multiple fracture
    ´Ù¹ß°ñÀý
  • nasal bone fracture
    ÄÚ»À°ñÀý
  • naso-orbital fracture
    ÄÚ´«È®°ñÀý
  • nasoethmoido-orbital fracture
    ÄÚ¹úÁý»À´«È®°ñÀý
  • neoplastic fracture
    Á¾¾ç°ñÀý
  • oblique fracture
    ºø°ñÀý, °æ»ç°ñÀý
  • occult fracture
    ¼ûÀº°ñÀý, ÀáÇà°ñÀý
  • odontoid process fracture
    Ä¡¾Æµ¹±â°ñÀý
  • open fracture
    °³¹æ°ñÀý
  • paratrooper fracture
    ³«Çϻ꺴°ñÀý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • fracture of neck of femur<³ª> fractura collifemoris
    ´ëÅð°ñ¸ñ(ºÎºÐ) °ñÀý, ´ëÅð(°ñ) °æºÎ(ÓÞ÷ÚÍé°æÝ») °ñÀý.
  • fracture of patella<³ª> fractura patellae
    ¹«¸­°ñ°ñÀý, ½½°³(°ñ)(ã£ËÏÍé )°ñÀý.
  • fracture of patella<³ª> fractura patellae
    ¹«¸­°ñ °ñÀý, ½½°³(°ñ)(ã£ËÏÍé ) °ñÀý.
  • fracture of penis
    À½°æÀýÁõ
  • fracture of penis<³ª> fractura p.
    À½°æÀýÁõ(ëäÌìï¹ñø) À½°æÇظéüÆÄ¿­( ëäÌìú­Øúô÷÷òæñ) .
  • fracture of radius<³ª> fractura radii
    ¿ä°ñ °ñÀý(èúÍéÍéï¹).
  • fracture of the frontal sinus
    ÀüµÎµ¿°ñÀý
  • fracture of tibia<³ª> fractura tibiae
    °æ°ñ(ÌëÍé) °ñÀý.
  • fracture of tooth
    Ä¡¾ÆÆÄÀý(öÍä³÷òï¹).
  • fracture of ulna<³ª> fractura ulnae
    ô°ñ(ô©Íé) °ñÀý.
  • fracture of vault of skull
    µÎ°³°ü °ñÀý, µÎ°³¿ø°³ºÎ(ÔéËÏê­ËÏÝ») °ñÀý, µÎ°³ ±Ã°­(ÔéËÏÏá˽)°ñÀý.
  • fracture of vault of skull
    µÎ°³°ü°ñÀý, µÎ°³¿ø°³ºÎ(ÔéËÏê­ËÏÝ»)°ñÀý, µÎ°³ ±Ã°­(ÔéËÏÏá˽)°ñÀý.
  • fracture of zygoma
    Çù°ñ( Íé)°ñÀý.
  • fracture pelvis
    °ñÀý °ñ¹Ý.
  • fracture reposition lever
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ) Áö·¿´ë.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cough fracture
    °úºÎ±âħ°ñÀý(¡­Íéï¹).
  • cough fracture
    ±âħ °ñÀý, °úºÎ ±âħ °ñÀý(¡­Íéï¹).
  • crush fracture
    ¾Ð±Ë °ñÀý(äâÏ÷Íéï¹), ÁÂ¸ê °ñÀý.
  • crush fracture luxation
    ¾Ð±Ë °ñÀý Å»°ñ(äâÏ÷Íéï¹÷­Ï¿), Á»ó °ñÀý Å»±¸.
  • delayed fracture
    Áö¿¬¼º °ñÀý(òÀæÅàõÍéï¹), Áö¿¬ Ä¡À¯ °ñÀý(òÀæÅö½ë¨Íéï¹).
  • depressed fracture
    ÇÔ¸ô °ñÀý(ùèÙÒÍéï¹).
  • direct fracture
    Á÷Á¢ °ñÀý(òÁïÈÍéï¹).
  • double fracture
    ÀÌÁß °ñÀý(ì£ñìÍéï¹), Áߺ¹ °ñÀý(ñìÜÜÍéï¹).
  • dyscrasic fracture
    ¼è¾à¼º °ñÀý(áñå°àõ Íéï¹).
  • endocrine fracture
    ³»ºÐºñ¼º °ñÀý(Ò®ÝÂÝôàõÍéï½).
  • epicondylar fracture
    »ó°ú °ñÀý(߾ΨÍéï¹), »ó°úºÎ °ñÀý(߾ΨݻÍéï¹).
  • epiphyseal fracture
    °ñ´Ü °ñÀý(¡­Íéï¹).
  • extracapsular fracture
    ÇǸ·¿Ü °ñÀý(ù¬Ø¯èâÍéï¹), °üÀý³¶¿Ü °ñÀý(Î¼ï½Ø¯èâÍéï¹).
  • finger fracture
    ¼Õ°¡¶ô °ñÀý, Áö°ñ °ñÀý(ò¦ÍéÍéï¹).
  • finger fracture
    ¼Õ°¡¶ô°ñÀý, Áö°ñ°ñÀý(ò¦ÍéÍé ï¹).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MS I, II, III, IV medical student-first, second, third, and fourth year
para III tripara
TCIII transcobalamin III
Fx Fracture; °ñÀý(Íéï¹)
CCF cancer coagulation factor; cardiolipin complement fixation; carotid-cavernous fistula; centrifuged c...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
HTLV-III Human T-lymphotropic virus type III
III CS III connecting segment
JH III Juvenile hormone III
pol III Polymerase III
P-III-P precollagen-III-peptide
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fracture of the frontal sinu
    µÎµ¿ °ñÀý
  • fracture of tooth
    Ä¡¾Æ ÆÄÀý
  • fracture of unfavorable
    ºÒ¾È °ñÀý
  • fracture of zygoma
    Çù°ñ °ñÀý
  • fracture pelvis
    °ñÀý °ñ¹Ý
  • fracture strength
    ÆÄÀý °­µµ
  • fussured fracture
    ¿­±¸ ÆÄÀý
  • humerus fracture
    »ó¿Ï°ñÀý, »ó¿Ï°ñ °ñÀý, »ó¹Ú°ñ °ñÀý
  • incomplete fracture
    ºÒ¿ÏÀü °ñÀý
    Ä¡°ü, Ä¡±Ù, ¾Ç°ñ µîÀÌ ºÎºÐÀûÀ¸·Î ÀÏÀ¸Å² °ñÀý. °æ¿ì¿¡ µû¶ó¼± °Ý½ÉÇÑ µ¿Åë°ú Á¾Ã¢ÀÌ ÇÔ²² ¿Â´Ù.
  • intertrochanteric fracture
    ÀüÀÚ°£ °ñÀý
  • intracapsular fracture
    °üÀý³¶ ³» °ñÀý
  • isolated fracture
    À¯¸® °ñÀý
  • joint fracture
    °üÀý °ñÀý
  • lead pipe fracture
    ¿¬°ü»ó °ñÀý
  • mandibular body fracture
    ÇϾÇü °ñÀý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
hyperlipoproteinaemia type III A rather uncommon form of familial hyperlipaemia characterised by the presence of lipoproteins of abnormal composition. The main abnormal lipoproteins are called beta-vldl and have a different apoprotein content and a higher proportion of cholesterol relative to triglyceride than normal vldl.
(12 Dec 1998)
NADH-Fe(III)EDTA oxidoreductase <enzyme> From cryptococcus albidus; catalyses the formation of nad+ and fe(ii)edta from NADH and fe(iii)edta; forms ethylene from 2-oxo-4-methylthiobutyric acid
Registry number: EC 1.6.99.-
(26 Jun 1999)
Sudan III A red stain, (C6H5)N==N(C6H4)N==N(C10H6)OH, used for neutral fat in histologic technique; it also stains the fatty envelope of the tubercle bacillus.
Synonym: Sudan red III.
(05 Mar 2000)
Sudan red III A red stain, (C6H5)N==N(C6H4)N==N(C10H6)OH, used for neutral fat in histologic technique; it also stains the fatty envelope of the tubercle bacillus.
Synonym: Sudan red III.
(05 Mar 2000)
deoxyribonucleases, type III site-specific <enzyme> Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as atpases. They exist as complexes with modification methylases of similar specificity.
The systems recognise specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.5
(12 Dec 1998)
DNA polymerase III <enzyme> An enzyme that aids in DNA replication. It has a number of different functions, such as: proofreading newly replicated DNA, removing nucleotides from the 3' end of the strand one by one, and binding nucleotides from the 5' end of the strand.
(09 Oct 1997)
ductus pharyngobranchialis III A narrow communication between the third branchial pouch and the pharynx in the embryo.
(05 Mar 2000)
type III acrocephalosyndactyly An autosomal dominant syndrome with variable expression of brachycephaly, maxillary hypoplasia, prominent ear crus, syndactyly, facial asymmetry, shallow orbits, telecanthus, and nasal septal deviation; may show mental retardation.
Synonym: Saethre-Chotzen syndrome.
(05 Mar 2000)
type III collagen Collagen characteristic of reticular fibres.
(05 Mar 2000)
type III familial hyperlipoproteinaemia Hyperlipoproteinaemia characterised by increased plasma levels of LDL, beta-lipoproteins, pre-beta-lipoproteins, cholesterol, phospholipids, and triglycerides; hypertriglyceridemia induced by a high carbohydrate diet, and glucose tolerance is abnormal; frequent eruptive xanthomas and atheromatosis, particularly coronary artery disease; biochemical defect lies in apolipoproteins; there are many varieties.
Synonym: carbohydrate-induced hyperlipaemia, dysbetalipoproteinaemia, familial hyperbetalipoproteinaemia and hyperprebetalipoproteinaemia, familial hypercholesterolaemia with hyperlipaemia.
(05 Mar 2000)
type III hyperlipoproteinaemia <biochemistry> An inherited disorder (gene defect) where both cholesterol and triglycerides are elevated in the same patient. This condition accelerates the effects of atherosclerosis and thus increases the risk of cardiovascular disease. Conditions such as hypothyroidism, obesity and diabetes enhances this risk.
Origin: Gr. Haima = blood
(27 Sep 1997)
type III hypersensitivity reaction An immunologic category of diseases evoked by the deposition of antigen-antibody or antigen-antibody-complement complexes on cell surfaces, with subsequent involvement of breakdown products of complement, platelets, and polymorphonuclear leukocytes, and development of vasculitis; nephritis is common. Arthus phenomenon and serum sickness are classic examples, but many other disorders, including most of the connective tissue disease's, may belong in this immunologic category; immune complex disease's can also occur during a variety of disease's of known aetiology, such as subacute bacterial endocarditis.
See: autoimmune disease.
Synonym: immune complex disorder, type III hypersensitivity reaction.
(05 Mar 2000)
type III mucopolysaccharidosis <syndrome> An error of the mucopolysaccharide metabolism, with excretion of large amounts of heparan sulfate in the urine and severe mental retardation with hepatomegaly; skeleton may be normal or may present mild changes similar to those in Hurler's syndrome; several different types (A, B, C, and D) have been identified according to the enzyme deficiency; autosomal recessive inheritance.
Synonym: type III mucopolysaccharidosis.
(05 Mar 2000)
exonuclease III An exonuclease enzyme which removes nucleotides one at a time from the 5'-end of duplex DNA which does not have a phosphorylated 3'-end.
(09 Oct 1997)
factor III In the clotting of blood, tissue factor or thromboplastin; it initiates the extrinsic pathway by reacting with factor VII and calcium to form factor VIIa.
See: thromboplastin.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á